Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-20 Sale |
2023-06-22 5:20 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,777 | $55 | $1,142,735 | 243,429 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 5:54 pm |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
26,000 | $54.67 | $1,421,529 | 0 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 5:47 pm |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
40,000 | $54.17 | $2,166,685 | 14,797 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-21 5:46 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
78,200 | $54.78 | $4,284,066 | 154,016 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:41 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
606 | $55.16 | $33,427 | 22,377 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:38 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
1,613 | $55.16 | $88,973 | 407,680 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:35 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
509 | $55.16 | $28,076 | 189,420 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:35 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
538 | $55.16 | $29,676 | 243,739 (Indirect Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 9:29 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
591 | $55.16 | $32,600 | 79,976 (Direct) |
View |
| 2022-09-19 Purchase(A) |
2023-06-15 9:26 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
520,000 | $29.69 | $15,440,000 | 522,168 (Indirect Direct) |
View |
| 2023-06-01 Sale |
2023-06-05 6:23 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $45.1 | $1,127,430 | 613,831 (Direct) |
View |
| 2023-05-19 Purchase |
2023-05-23 9:55 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
520,000 | $29.69 | $15,440,000 | 522,168 (Indirect Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 8:28 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $45.07 | $1,126,860 | 652,373 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 4:55 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $37.94 | $948,576 | 480,161 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 4:21 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $46.65 | $1,166,338 | 506,867 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 5:25 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $49.06 | $1,226,395 | 531,867 (Direct) |
View |
| 2023-01-13 Sale |
2023-01-18 5:30 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $50.53 | $252,651 | 81,268 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 6:46 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $51.27 | $1,281,751 | 556,867 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 5:56 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
8,777 | $54.64 | $479,560 | 328,232 (Indirect Direct) |
View |
| 2022-12-28 Sale |
2022-12-30 4:26 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,016 | $50.97 | $1,122,125 | 330,882 (Direct) |
View |
| 2022-12-27 Sale |
2022-12-29 5:41 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $49.77 | $995,323 | 508,281 (Direct) |
View |
| 2022-12-27 Sale |
2022-12-28 6:30 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $49.57 | $619,609 | 383,025 (Indirect Direct) |
View |
| 2022-12-12 Sale |
2022-12-13 8:24 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $43.23 | $216,137 | 172,647 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-05 4:36 pm |
Akero Therapeutics Inc. | AKRO | Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd Former 10% owner |
1,636,000 | $43.5 | $71,166,000 | 3,271,829 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-20 Exercise |
2023-06-22 5:20 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
17,500 | $0 | 243,429 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-22 5:20 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
17,500 | $7.009 | 243,429 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:54 pm |
N/A 2030-06-09 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
26,000 | $0 | 0 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:54 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
26,000 | $25.04 | 0 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:47 pm |
N/A 2029-04-02 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
40,000 | $0 | 14,797 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:47 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
40,000 | $7.01 | 14,797 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:46 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
40,000 | $0 | 154,016 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-21 5:46 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
40,000 | $0.61 | 154,016 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-05 6:23 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 613,831 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-05 6:23 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
3,670 | $6.36 | 613,831 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-05 6:23 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
21,330 | $0.615 | 613,831 (Direct) |
View |
| 2023-04-18 Exercise |
2023-05-03 8:28 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
65,000 | $0 | 652,373 (Direct) |
View |
| 2023-04-18 Exercise |
2023-05-03 8:28 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
65,000 | $0.615 | 652,373 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 4:55 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0 | 480,161 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 4:55 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0.615 | 480,161 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2023-03-14 4:25 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
641 | $43.47 | 22,983 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2023-03-14 4:20 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
701 | $43.46 | 80,567 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2023-03-14 4:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
634 | $43.47 | 244,277 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2023-03-14 4:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
603 | $43.47 | 189,929 (Direct) |
View |
| 2023-03-10 Tax Withholding |
2023-03-14 4:18 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
1,706 | $43.47 | 369,293 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 4:21 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0 | 506,867 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 4:21 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0.615 | 506,867 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 5:25 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0 | 531,867 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 5:25 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0.615 | 531,867 (Direct) |
View |
| 2023-01-10 Option Award |
2023-01-11 7:51 pm |
N/A 2033-01-09 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick See Remarks |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 6:46 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0 | 556,867 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 6:46 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
25,000 | $0.615 | 556,867 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 5:56 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
8,777 | $0 | 328,232 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 5:56 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
8,777 | $0.615 | 328,232 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 4:26 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
9,516 | $0 | 330,882 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 4:26 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
9,516 | $28.35 | 330,882 (Direct) |
View |
| 2022-12-27 Exercise |
2022-12-29 5:41 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $0 | 508,281 (Direct) |
View |
| 2022-12-27 Exercise |
2022-12-29 5:41 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $7.009 | 508,281 (Direct) |
View |
| 2022-12-27 Exercise |
2022-12-28 6:30 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $0 | 383,025 (Direct) |
View |
| 2022-12-27 Exercise |
2022-12-28 6:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
11,778 | $6.36 | 383,025 (Direct) |
View |
| 2022-12-27 Exercise |
2022-12-28 6:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
722 | $0.615 | 383,025 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:52 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
29,073 | $0 | 87,221 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:49 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
29,073 | $0 | 87,221 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:49 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
29,073 | $0 | 87,221 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:47 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
29,073 | $0 | 87,221 (Direct) |
View |
| 2022-12-16 Exercise |
2022-12-20 7:46 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
8,500 | $0 | 829,873 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 7:46 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
87,220 | $0 | 829,873 (Direct) |
View |
| 2022-12-16 Exercise |
2022-12-20 7:46 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
8,500 | $0.615 | 829,873 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:30 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
287,931 | $0 | 598,079 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:30 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
105,574 | $0 | 289,411 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:30 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
105,574 | $0 | 328,828 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:28 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
105,574 | $0 | 110,003 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:24 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
105,574 | $0 | 172,647 (Direct) |
View |